Apellis Pharmaceuticals shares owned by Bayesian Capital Management
Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Bayesian Capital Management
from 13F filings
Historical chart of Bayesian Capital Management investment in Apellis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Apellis Pharmaceuticals held by Bayesian Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apellis Pharmaceuticals by Bayesian Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $527k | 13k | 40.23 |
| 2025-09-30 | $577k | 26k | 22.63 |
| 2025-03-31 | $829k | 38k | 21.87 |
| 2024-09-30 | $900k | 31k | 28.84 |
| 2023-12-31 | $1.0M | 17k | 59.86 |
| 2023-06-30 | $831k | 9.1k | 91.10 |
| 2023-03-31 | $1.2M | 18k | 65.96 |
| 2022-06-30 | $525k | 12k | 45.26 |
| 2022-03-31 | $711k | 14k | 50.79 |
More positions owned by Bayesian Capital Management
View all positions for Bayesian Capital Management